---
title: "Aimei Health Terminates Planned Business Combination Agreement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292119212.md"
description: "Aimei Health Technology Co., Ltd. (AFJK) announced the termination of its Business Combination Agreement with United Hydrogen Group Inc. on July 8, 2026, after failing to close by the contractual deadline. The SPAC will now seek alternative acquisition targets, maintaining its strategy despite the collapsed deal."
datetime: "2026-07-08T21:52:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292119212.md)
  - [en](https://longbridge.com/en/news/292119212.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292119212.md)
generator: "portal-rs"
---

# Aimei Health Terminates Planned Business Combination Agreement

Aimei Health Technology Co., Ltd ( (AFJK) ) has issued an announcement.

On July 7, 2026, Aimei Health Technology Co., Ltd. delivered a notice terminating its Business Combination Agreement, originally signed on June 19, 2024 and amended on June 6, 2025, with United Hydrogen Group Inc. and related Cayman Islands entities after the transaction failed to close by the contractual outside date. The company announced the termination publicly on July 8, 2026, signaling the collapse of the planned merger and a renewed search for an alternative target, which may affect deal expectations for investors but leaves Aimei Health pursuing other potential transactions in line with its acquisition-focused mandate.

Chief Executive Officer and Director Xie Junheng acknowledged that the parties were unable to complete the combination within the required timeframe but emphasized confidence in Aimei Health’s ability to identify and execute a compelling transaction going forward. While the decision ends the proposed tie-up with United Hydrogen, the company’s stated intent to continue pursuing a new deal suggests its capital and listing vehicle remain in play for future mergers, with implications for both its own shareholders and potential counterparties.

**More about Aimei Health Technology Co., Ltd**

Aimei Health Technology Co., Ltd. is a Nasdaq-listed special purpose acquisition company focused on identifying and executing business combinations, rather than operating an ongoing business in a specific industry segment. The company’s strategy centers on sourcing and completing transactions with suitable targets to deliver value to its shareholders in the capital markets.

**Average Trading Volume:** 20,028

**Technical Sentiment Signal:** Hold

**Current Market Cap:** $86.34M

### Related Stocks

- [AFJK.US](https://longbridge.com/en/quote/AFJK.US.md)
- [AFJKR.US](https://longbridge.com/en/quote/AFJKR.US.md)
- [AFJKU.US](https://longbridge.com/en/quote/AFJKU.US.md)

## Related News & Research

- [Aimei Health issues USD 34,331 interest-free promissory note to Aimei Health Ltd to fund trust extension payment](https://longbridge.com/en/news/295142386.md)
- [Aimei Health issues $34,330.96 promissory note to Aimei Health Ltd for SPAC extension funding](https://longbridge.com/en/news/291839294.md)
- [MAX Power Mining (CSE: MAXX) (OTC: MAXXF) to Present Lawson Natural Hydrogen Program at IMAGE ’26](https://longbridge.com/en/news/296250628.md)
- [Primary Hydrogen Enters Nova Scotia's Cumberland Basin Natural Hydrogen District with Staking of the Northumberland Project | HNATF Stock News](https://longbridge.com/en/news/296125091.md)
- [HPQ Silicon partner Novacium to present HyDRAS hydrogen research at COM 2026 conference](https://longbridge.com/en/news/296488795.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**